
PMC:7376974 / 57538-57764
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T235 | 160-175 | Body_part | denotes | heparan sulfate | http://purl.org/sig/ont/fma/fma63023 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1005 | 135-145 | Chemical | denotes | sulfonates | MESH:D000476 |
1006 | 160-175 | Chemical | denotes | heparan sulfate | MESH:D006497 |
1007 | 203-223 | Disease | denotes | SARS-Cov-2 infection | MESH:C000657245 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T152 | 203-207 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T153 | 214-223 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T518 | 43-44 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T54669 | 54-63 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T5643 | 135-145 | Chemical | denotes | sulfonates | http://purl.obolibrary.org/obo/CHEBI_33543 |
T61195 | 160-175 | Chemical | denotes | heparan sulfate | http://purl.obolibrary.org/obo/CHEBI_28815 |
T102 | 160-167 | Chemical | denotes | heparan | http://purl.obolibrary.org/obo/CHEBI_24500 |
T82802 | 168-175 | Chemical | denotes | sulfate | http://purl.obolibrary.org/obo/CHEBI_16189 |
LitCovid-PD-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue | glyco_epitope_db_id |
---|---|---|---|---|---|
T9 | 160-175 | GlycoEpitope | denotes | heparan sulfate | http://www.glycoepitope.jp/epitopes/EP0086 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T367 | 0-226 | Sentence | denotes | The mechanical disruption of the capsid is a peculiar antiviral mechanism associated with some NMs. In particular, the use of specific sulfonates able to mimic heparan sulfate can be also used to target SARS-Cov-2 infection.95 |